Table 2.
DCIS | Variable | OR | 95% CI | Coefficient | SE | p-value |
Total | ER/PR-negative | 4.67 | 1.87–11.70 | 1.54 | 0.47 | 0.0010 |
HER2-positive | 0.39 | 0.17–0.93 | −0.93 | 0.44 | 0.0333 | |
CK 5/6-positive | 0.22 | 0.10–0.48 | −1.5 | 0.39 | 0.0001 | |
Low-grade | CK 5/6-positive | 0.22 | 0.09–057 | −1.5 | 0.49 | 0.0019 |
High-grade | Triple-positive | 0.09 | 0.02–0.51 | −2.37 | 0.87 | 0.006 |
CK 5/6-positive | 0.28 | 0.09–0.93 | −1.24 | 0.59 | 0.04 |
ER: estrogen receptor; PR: progesterone receptor; HER2: human epidermal growth factor 2; CK 5/6: cytokeratin 5/6; OR: odds ratio; SE: standard error.